PPPrajitha Pradeep

Prajitha Pradeep

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Prajitha Pradeep has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cannabidiol modulates spontaneous recovery through distinct and conserved transcriptomic signatures in mPFC subregions

    by Minji Son, Inwoong Song, Prajitha Pradeep, Bomi Chang, Matthew J. Girgenti, Cha Young Kim, Jae Cheol Jeong, Boyoung Lee

    Cannabidiol (CBD) has shown therapeutic potential for post-traumatic stress disorder (PTSD) by reducing spontaneous recovery (SR), yet the underlying mechanisms remain unclear. We examined the effects of CBD on SR in male and female mice and found greater behavioral efficacy in males. To uncover the molecular basis of these effects, we performed transcriptomic profiling of the prelimbic (PL) and infralimbic (IL) subregions of the medial prefrontal cortex (mPFC). We identified distinct and overlapping SR-associated gene sets in each subregion, and CBD shifted the expression of a significant subset of these genes toward non-stressed control levels, including genes involved in retrograde endocannabinoid signaling. Cross-species comparisons with human PTSD transcriptomic datasets revealed conserved gene alterations within each subregion, suggesting shared molecular signatures between mouse SR and human PTSD. These findings highlight region-specific and conserved pathways through which CBD may exert therapeutic effects and provide mechanistic insight to advance CBD-based interventions for PTSD-associated spontaneous recovery.

  • Open Access

    Abnormal O-glycan sialylation in the mPFC contributes to depressive-like behaviors in male mice

    by Youngsuk Seo, Inwoong Song, Ki Jung Kim, Bomi Chang, Prajitha Pradeep, Woo Suk Roh, Woojin Won, Jinhyeong Joo, Myeongju Kim, Jae Cheol Jeong, et al.

    Depression presents challenges in understanding its biological basis and developing effective treatments. Posttranslational modifications provide critical insights into molecular mechanisms of disorders, yet their role in depression remains underexplored. Glycosylation has been particularly difficult to study due to its heterogeneous nature and analytical challenges, despite its potential to uncover previously unknown mechanisms. In this study, we demonstrate how chronic stress alters region-specific O-glycosylation across multiple brain regions, with a particular focus on the prefrontal cortex (PFC). Our findings reveal significant changes in sialylated O-glycosylation patterns mediated by St3gal1 , a sialyltransferase essential for O-glycosylation. Notably, knockdown of St3gal1 in nonstressed mice induced depressive-like behaviors, whereas its overexpression in stressed mice alleviated depressive symptoms, underscoring its regulatory role in stress resilience. In addition, we identify potential glycoprotein targets and downstream regulators of St3gal1 , including neurexin 2 (NRXN2) in the medial PFC (mPFC), offering insights into molecular pathways linking O-glycosylation to depressive-like behaviors.


  • Top Cited Papers
    Open Access

    Glycosylation and behavioral symptoms in neurological disorders

    by Prajitha Pradeep, Hyeyeon Kang, Boyoung Lee

    Glycosylation, the addition of glycans or carbohydrates to proteins, lipids, or other glycans, is a complex post-translational modification that plays a crucial role in cellular function. It is estimated that at least half of all mammalian proteins undergo glycosylation, underscoring its importance in the functioning of cells. This is reflected in the fact that a significant portion of the human genome, around 2%, is devoted to encoding enzymes involved in glycosylation. Changes in glycosylation have been linked to various neurological disorders, including Alzheimer’s disease, Parkinson’s disease, autism spectrum disorder, and schizophrenia. Despite its widespread occurrence, the role of glycosylation in the central nervous system remains largely unknown, particularly with regard to its impact on behavioral abnormalities in brain diseases. This review focuses on examining the role of three types of glycosylation: N-glycosylation, O-glycosylation, and O-GlcNAcylation, in the manifestation of behavioral and neurological symptoms in neurodevelopmental, neurodegenerative, and neuropsychiatric disorders.